CLB Core Laboratories N V

Price (delayed)

$24.17

Market cap

$1.13B

P/E Ratio

29.84

Dividend/share

$0.04

EPS

$0.81

Enterprise value

$1.33B

Core Laboratories N.V. is a leading provider of proprietary and patented reservoir description and production enhancement services and products used to optimize petroleum reservoir performance. The Company has over 70 ...

Highlights
Core Laboratories N V's EPS has soared by 59% YoY and by 2.5% from the previous quarter
CLB's net income has soared by 58% year-on-year and by 2.3% since the previous quarter
The stock's price to earnings (P/E) is 23% more than its last 4 quarters average of 24.5

Key stats

What are the main financial stats of CLB
Market
Shares outstanding
46.9M
Market cap
$1.13B
Enterprise value
$1.33B
Valuations
Price to book (P/B)
4.88
Price to sales (P/S)
2.22
EV/EBIT
23.69
EV/EBITDA
18.55
EV/Sales
2.6
Earnings
Revenue
$511.07M
EBIT
$56.18M
EBITDA
$71.76M
Free cash flow
$23.04M
Per share
EPS
$0.81
Free cash flow per share
$0.49
Book value per share
$4.95
Revenue per share
$10.91
TBVPS
$10.28
Balance sheet
Total assets
$587.95M
Total liabilities
$350.53M
Debt
$212.28M
Equity
$232.16M
Working capital
$143.58M
Liquidity
Debt to equity
0.91
Current ratio
2.68
Quick ratio
1.52
Net debt/EBITDA
2.75
Margins
EBITDA margin
14%
Gross margin
21.1%
Net margin
7.3%
Operating margin
11.1%
Efficiency
Return on assets
6.3%
Return on equity
16.7%
Return on invested capital
9.3%
Return on capital employed
11.2%
Return on sales
11%
Dividend
Dividend yield
0.17%
DPS
$0.04
Payout ratio
4.9%

CLB stock price

How has the Core Laboratories N V stock price performed over time
Intraday
-0.74%
1 week
5.55%
1 month
24.59%
1 year
-2.54%
YTD
36.86%
QTD
19.12%

Financial performance

How have Core Laboratories N V's revenue and profit performed over time
Revenue
$511.07M
Gross profit
$108.05M
Operating income
$56.73M
Net income
$37.52M
Gross margin
21.1%
Net margin
7.3%
CLB's net income has soared by 58% year-on-year and by 2.3% since the previous quarter
CLB's net margin has soared by 55% YoY
Core Laboratories N V's operating income has increased by 17% YoY and by 3.8% QoQ
The operating margin has increased by 16% YoY and by 3.7% from the previous quarter

Growth

What is Core Laboratories N V's growth rate over time

Valuation

What is Core Laboratories N V stock price valuation
P/E
29.84
P/B
4.88
P/S
2.22
EV/EBIT
23.69
EV/EBITDA
18.55
EV/Sales
2.6
Core Laboratories N V's EPS has soared by 59% YoY and by 2.5% from the previous quarter
The stock's price to earnings (P/E) is 23% more than its last 4 quarters average of 24.5
The P/B is 38% below the 5-year quarterly average of 7.9 but 14% above the last 4 quarters average of 4.3
CLB's equity is up by 19% YoY and by 3.3% from the previous quarter
CLB's price to sales (P/S) is 17% higher than its last 4 quarters average of 1.9

Efficiency

How efficient is Core Laboratories N V business performance
The ROA has soared by 54% YoY
The return on equity rose by 28% year-on-year but it has declined by 2.3% since the previous quarter
Core Laboratories N V's ROS has increased by 15% YoY and by 3.8% from the previous quarter
The return on invested capital is up by 15% year-on-year and by 3.3% since the previous quarter

Dividends

What is CLB's dividend history
DPS
$0.04
Dividend yield
0.17%
Payout ratio
4.9%
Recent dividends

Financial health

How did Core Laboratories N V financials performed over time
The total assets is 68% greater than the total liabilities
The quick ratio has increased by 14% YoY and by 8% QoQ
CLB's current ratio is up by 13% year-on-year and by 6% since the previous quarter
CLB's debt is 9% less than its equity
The debt to equity has decreased by 24% YoY and by 5% QoQ
CLB's equity is up by 19% YoY and by 3.3% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.